中文版 | English

在结果中检索

IOCAS-IR
（本次检索基于用户作品认领结果）

浏览/检索结果: 共3条，第1-3条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2024, 卷号: 173, 页码: 10
作者:  Deng, Zhenzhen;  Qishan, Suo;  Zhang, Quanbin;  Wang, Jing;  Yue, Yang;  Geng, Lihua;  Wu, Ning
收藏  |  浏览/下载：4/0  |  提交时间：2024/06/04
Fucoidan  Tumor microenvironment  Macrophages  Oxaliplatin  
Fucoidan, as an immunostimulator promotes M1 macrophage differentiation and enhances the chemotherapeutic sensitivity of capecitabine in colon cancer 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 卷号: 222, 页码: 562-572
作者:  Deng, Zhenzhen;  Wu, Ning;  Suo, Qishan;  Wang, Jing;  Yue, Yang;  Geng, Lihua;  Zhang, Quanbin
Adobe PDF(8782Kb)  |  收藏  |  浏览/下载：181/0  |  提交时间：2023/01/04
Capecitabine  Tumor microenvironment  Macrophages  TLR4  Fucoidan  
Low molecular weight fucoidan fraction LF2 improves metabolic syndrome via up-regulating PI3K-AKT-mTOR axis and increasing the abundance of Akkermansia muciniphila in the gut microbiota 期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 卷号: 193, 页码: 789-798
作者:  Deng, Zhenzhen;  Wu, Ning;  Wang, Jing;  Geng, Lihua;  Yue, Yang;  Wang, Fahe;  Zhang, Quanbin
Adobe PDF(3607Kb)  |  收藏  |  浏览/下载：218/0  |  提交时间：2022/02/18
Fucoidan  Metabolic syndrome  Gut microbiota